Zyla Life Sciences Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Zyla Life Sciences reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $39.16 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-05-10
- Zyla Life Sciences net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $39.16M.
- Zyla Life Sciences net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-12-31 was -$2.00K.
- Zyla Life Sciences net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-09-30 was $21.49M, a 73.39% decline year-over-year.
- Zyla Life Sciences net cash provided by (used in) financing activities, continuing operations for the quarter ending 2015-12-31 was -$68.00K.
- Zyla Life Sciences net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $21.65M, a 85.79% decline from fiscal 2015.
- Zyla Life Sciences net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $152.29M, a 127.36% increase from fiscal 2014.
- Zyla Life Sciences net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $66.98M, a 394.08% increase from fiscal 2013.
- Zyla Life Sciences net cash provided by (used in) financing activities, continuing operations for fiscal 2013 was $13.56M, a 64.97% increase from fiscal 2012.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | $39.16M 10-Q · filed 2017-05-10 | $39.16M derived: sum of 2 quarters · filed 2017-05-10 | $60.66M derived: sum of 3 quarters · filed 2017-05-10 | |
| 2016-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $21.49M derived: sum of 2 quarters · filed 2017-03-13 | $21.65M 10-K · filed 2017-03-13 | |
| 2016-09-30 | $21.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $21.65M 10-Q · filed 2016-11-08 | ||
| 2016-06-30 | $155.00K 10-Q · filed 2016-08-05 | |||
| 2015-12-31 | -$68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $80.72M derived: sum of 2 quarters · filed 2017-03-13 | $137.68M derived: sum of 3 quarters · filed 2017-03-13 | $152.29M 10-K · filed 2017-03-13 |
| 2015-09-30 | $80.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $137.75M derived: sum of 2 quarters · filed 2016-11-08 | $152.36M 10-Q · filed 2016-11-08 | $152.36M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $56.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $71.58M 10-Q · filed 2016-08-05 | $71.58M derived: sum of 3 quarters · filed 2017-03-13 | $71.58M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $14.61M 10-Q · filed 2016-05-10 | $14.61M derived: sum of 2 quarters · filed 2017-03-13 | $14.61M derived: sum of 3 quarters · filed 2017-03-13 | $14.52M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | -$92.00K derived: sum of 3 quarters · filed 2017-03-13 | $66.98M 10-K · filed 2017-03-13 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$92.00K derived: sum of 2 quarters · filed 2015-11-06 | $66.98M 10-Q · filed 2015-11-06 | $65.64M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | -$92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $66.98M 10-Q · filed 2015-08-07 | $65.64M derived: sum of 3 quarters · filed 2016-03-11 | $75.54M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $67.07M 10-Q · filed 2015-05-08 | $65.73M derived: sum of 2 quarters · filed 2016-03-11 | $75.63M derived: sum of 3 quarters · filed 2016-03-11 | |
| 2013-12-31 | -$1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $8.56M derived: sum of 2 quarters · filed 2016-03-11 | $13.56M 10-K · filed 2016-03-11 | |
| 2013-09-30 | $9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $14.90M 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $5.00M 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | $8.22M 10-K · filed 2015-03-16 |